A Phase 1b Food Effect Study of the First-in-Class, Oral, Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients with Advanced Sarcomas
A Phase 1b Food Effect Study of the First-in-Class, Oral, Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients with Advanced Sarcomas